Chih-hsing Ho

Chih-hsing Ho is a tenured Associate Research Fellow (equivalent to Associate Professor) at the Institute of European and American Studies, Academia Sinica, Taiwan. Since February 2021 he has held a joint appointment at Academia Sinica’s Research Center for Information Technology Innovation (2021–2024) and has been a Research Fellow at the Centre for Medical Ethics and Law, University of Hong Kong since 2019. He also serves on several high-level government advisory committees in Taiwan, including the Advisory Committee on Digital Economy Development (Ministry of Digital Affairs, 2025–present) and the Technology Policy Advisory Committee (Ministry of Health and Welfare, 2023–present).

Education

• Ph.D. in Law, London School of Economics and Political Science (LSE)
• J.S.M., Stanford Law School
• LL.M., Columbia Law School
• LL.B., College of Law, National Taiwan University

Research Interests

Dr. Ho’s scholarship integrates law, medicine, and emerging technologies. His core interests include:

• Legal aspects of translational medicine and biobanking – designing governance frameworks for large-scale genomic and health-data repositories.
• Big-data privacy and data-protection law – analysing GDPR compliance, cross-border data transfers, and secondary use of health data.
• AI governance and law – exploring regulatory strategies for generative AI in healthcare, algorithmic accountability, and human-robot interaction.
• Law, medicine and global health – comparative studies on genetic non-discrimination policies, data sovereignty, and equitable access.
• Law and anthropology – examining group-consent models informed by indigenous perspectives and socio-legal contexts.

Publications Trajectory

Between 2018 and 2024, Ho has published extensively on the intersection of data-protection law and biomedical research. His work traces an evolution from foundational analyses of GDPR challenges for biobanks (2018) to cutting-edge studies on generative-AI regulation (2024). Recurring themes include comparative governance of health-data infrastructures (FinnGen, NHS England, Taiwan Biobank), privacy-preserving legal architectures for AI, and consensus-building methodologies for genetic non-discrimination policies. His recent co-authored Delphi consensus statement in JAMA Network Open exemplifies his commitment to evidence-based policy design.

Scientific Awards & Grants

• National Science and Technology Council Award for Outstanding Scholars, Taiwan (2024–2025; 2021–2022; 2019–2020)
• Ministry of Science and Technology Recruiting Outstanding Scholars Award, Taiwan (2014–2017)
• Academia Sinica Recruiting Outstanding Scholars Award, Taiwan (2014–2016)
• LSE Olive Stone Memorial Scholarship (2007–2009)
• LSE Morris Finer Award for Socio-Legal Studies (2007–2008)
• LSE Wedderburn Writing-Up Grant (2010–2012)
• Ministry of Education Studying Abroad Scholarship, Taiwan (2007–2009)

Grants & Governance Roles

Ho currently convenes the AI Governance Laboratory at IEAS (2023–present) and sits on more than a dozen national ethics and policy boards, including:

• Legal Affairs Committee, Academia Sinica (2025–present)
• Committee on Risk Assessment of Generative AI, Academia Sinica (2025–present)
• Ethics and Governance Council (EGC) of Taiwan Biobank (2019–present)
• Multiple Institutional Review Boards (IRB-BM, Academia Sinica; CDC Taiwan; Tri-Service General Hospital; Development Center for Biotechnology)

Labs & Teams

He leads the AI Governance Laboratory at the Institute of European and American Studies, fostering interdisciplinary collaboration among legal scholars, computer scientists, and medical ethicists to craft responsible AI policies. Previously, he convened the EU Core Research Group (2017–2020), promoting comparative European studies at Academia Sinica.